The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
True, assuming the £500k all relates to future cost, and not cost already accrued.
Either Yates has been forced to take equity because there’s no cash, or he wants to take equity. If the latter, then it suggests strongly that he sees real growth potential in the project and expects it to accelerate progress to cash break even and beyond
On the face of it this sounds great. However, the company will be incurring cash costs to generate up to £500,000 in fees that will be paid for in shares in a company that’s not been around very long and for which there is an absence of financial information. How does this help in getting ABDX to a cash flow positive position?
Don’t really know what to make of this - scattergun thoughts are;
I can find nothing about Devyn LLC, Find Out From Home LLC, or Yannick Namia, which is odd.
The “LLC” suggests they’re US companies. That’s been a real growth area for us.
A £500k stake for 23% values FOFH LLC at over £2m. Not bad for a new unproven enterprise.
Are we investing because we want to, or because they can’t pay the fee? Great if the former - suggests real enthusiasm and potential.
I’m wondering if these new tests might be molecular or based on Senzo ALT tech
Honestly, on the face of it it looks great, but it’s difficult to add colour because there’s little else to go on.
As an aside, it’s interesting they brought the interims forward only to announce a succession of news thereafter.
Exactly. More positive news today. All building nicely at ABDX, albeit slowly....
* Four sexually transmitted disease lateral flow self-tests complete design freeze.
* Exclusive global manufacturing plus UK and European distribution rights via strategic partnership with USA-based Find Out From Home LLC.
Good luck, Brighty
There’s been a constant flow of positive news lately which is building a momentum. They’re building a solid base and things are looking very good atm… future looks very bright here.
Some momentum here at last
Yup. We’ve spent the last couple of years rebuilding on a prudent fee for service model, diligently growing our quality customer base. Through 2024 we will see more and more customers commercialising and requiring manufacture. That hopefully will produce a regular and growing annuity income from which further growth can be funded.
This thing sells itself imo. We just need more investors to look under the bonnet, but I’m happy to keep accumulating until they do.
God, I love this company. Quietly beavering away. Confidently disregarding the need for silly hype other would-be if they could -be companies resort to. Abingdon have dusted off past adversity, they clearly know where they are going, have outstanding expertise in commercialising and are innovating a whole new contemporary industry with few competitors at this point. I can't believe how far they have come and us LT shareholders are in an incredible position to gain from this ridiculous share price at the moment. Huge thanks to Muck165 and others for bringing all of this to light. Patience will be rewarded here. No doubt about it at all in my mind.
Wow, I think the vitamin D and iron deficiency rapid tests probably have even more marketability than the pregnancy test to be honest. Especially of interest to women who can be concerned over iron levels during different times of their life. We are all more concerned about vitamin D levels now too since covid. I take vitamin D every day.
A bit more colour to the ABDX proposition
https://www.abingdonsimplytest.com/own-brand-diagnostics-products-navigating-challenges/
ABDX certainly now pushing this OEM/private label as a new service to retailers
https://www.abingdonsimplytest.com/knowledge-centre/private-own-label-solutions/
This one, from the Co-owner and Director of Crest Medical makes for interesting, and potentially exciting, reading.
“ Delighted to have developed and worked with Abingdon Health plc and Boots UK on these two diagnostic tests … keep an eye out over the next few weeks for the next launch of a revolutionary test!!”
Does he mean another test in conjunction with ABDX - fair bet I think.
https://www.linkedin.com/posts/matthew-courtney-5ab14879_boots-to-sell-its-first-own-brand-self-tests-activity-7176600829678755841-nZVW?utm_source=share&utm_medium=member_desktop
Thanks gotreal.
From the RNS: "Diagnostic tests are another great addition to the Crest Medical portfolio as we look to expand further and deepen our partnership with Boots. Abingdon Health are at the forefront of this expansion and we are thrilled to be partnering with a company who are leaders in lateral flow diagnostics."
It suggests to me that Crest are a strategic supplier to Boots who probably, at some point, rationlised thier supply chain to a few key suppliers and part of the agreement was that Boots would only procure through them for certain types of products. Not an unusual arrangement in big corporates as the amount of red tape that has to be gone through to set up a new supplier can take literally years. I was involved in one with a large telco that took 3.5 years.
I hadn’t looked for a while, but seems to me that all of the tests on the AST site have had a branding makeover, and now look like more like proper retail offerings as opposed to medical supplies.
And noticeably, two of the tests now have a very retail oriented instruction for use video - you guessed it, Vitamin D and Iron Deficiency.
Would appreciate anyone's help on something.
As far as I understand it, Boots are effectively going to be white labelling Abingdon Simply Test products. We make them, they buy them from us at a margin, they stick their branded packing around them (or we may do it for them) and they sell them to retail for a margin.
So where does "our partner" Crest Medical fit in? Ae they someone we've made a distribution agreement with, and they are distributing to Boots?
I don't know if it really matters too much apart from the fact that presumably Crest want some piece of the pie.
Thanks
For info - an insight into what industry thinks about the Boots move
https://www.linkedin.com/posts/fernando-ammann-2b697698_healthcare-technology-innovation-activity-7176302251865432064-xh6L?utm_source=share&utm_medium=member_desktop
So.. now you have all had a taste of Wynbore
This mornings example is a rerun of everything he's ever said and argued on the AVC board.. for.. years. He loves to write essays about what he thinks. My advice is don't engage with comments and questions.. you will just get more of the same.. he is a narcissist and a manipulator with far too much time on his hands.
I wanted to warn you Muck when he started.. but decided best find out for yourself!
I've said my bit.. i'll go back in my shell.. and see what happens
I go out of my way to rebutt false assertions but it can be quite wearing to do so as there are plainly paid teams of people operating on some boards who aim to flood them with misinformation to the point where reality becomes hidden in the haze. But in this post-truth world I think it is even more important to challenge the fabrications as if not they become accepted facts which can too easily influence the unwary.
"and I certainly was not implying anything about anyone posting here."
No, I quite accept (and didn't think) that you were, gotreal.
It tends to be those types you refer to don't actually have any affect on the SP. I am not saying they won't or can't influence some, but not enough to make any difference to the SP.
Also I have to say, I don't have an enormous amount of sympathy for those that are influenced by rampers or derampers.
If you have bought into a stock then there should have been some sort of plan and expectation. Reacting to an anonymous poster views is down to that individual. If the poster makes a case, then question them and see if more info is revealed to support their view. If they can't, then discard it.
Most rampers/derampers opinions can usually easily be seen to be what they actually are.
Not all traders behave poorly, wyndrum, but many do. And like it or not, and I have never seen evidence one way or the other as to the potential effects of online discussion on share prices, although GameStop might make an interesting study, many do think they can unsettle holders and influence their behavour thereby creating volatility by being deceitful or preying on their all too human natures, which basically are fearful. When money is concerned nothing is too low..... but as I say, not all and I certainly was not implying anyhthing about anyone posting here.
Gotreal, the pejorative language you use does indeed highlight the tension you believe to be present.
Certainly most stocks can be manipulated by a larger buyer or seller creating a "false" impression. (including some indicies)
Unfortunately the human condition, where money is involved, all too easily attracts deceit and lies and scams.
However, having said that, its not quite as easy as you think. creating a false market is risky and expensive. and requires a concerted effort maybe including the broker. As a result it tends not to be done on a whim, and certainly in my experience nothing, absolutely nothing posted on BB's such as these has any effect on a SP.
And what is a Trader? someone who buys and sells more often than a LTHolder, but how long is longer?
Personally I would define it more as: Anyone who manages their own portfolio is in fact a "trader". They make conscious decisions to buy or sell, dependent on the news and info they have at any given time. The time they hold a stock is not a relevant factor.
Both short term or long term, the goal is the same: to maximise returns. The label given to the timeframe of the holding is imo, as I say irrelevant.
Cheers
And that's where the tension is between the two groups. Fundamental investors invest their money in support of the enterprise in the hope and belief that with their support and if wisely run it will in time grow and prosper and they will benefit from that hard work and faith that businesses require to weather difficult times. Short term "investors", aka traders, as you said your self, don't care about the company; it is merely an instrument of profit potential. And when you throw the ability to profit when the company's SP falls into the mix it is easy to see why it becomes toxic. Most fundamentalists don't care about what traders do as in time their "impact" is irrelevant, if they do it quietly, behind the scenes (although the advent of Hedge funds has changed that, as such massive forces can permanently affect the fundamental stability of companies). It is when those traders, in an effort to try to create volatility, use lies and distortions, fear and uncertainty to try to enrich themselves, as you see in commentary on BBs, that the conflict is fomented. It can bring out the worst of human nature and be very ugly.
There seems to be 2 choices, TA or FA (Fundamental Analysis).
The "problem" with FA is that the SP is never representative of the company. To begin with the "latest" results, will be 6-12 weeks out of date, so its looking back. But the market, based on this out of date info will estimate (guess) what the near future (3-6, maybe 12 months) what the profits of the company will be.
So at no time is the SP ever an accurate reflection of the company. So, it then becomes on balance, what the market thinks will happen and then you are int o crowds and are they predictable yada yada yada.
The perhaps main difference then becomes timescales.
TA is looking much more short term (as is the nature of crowds to be at times volatile in their actions) whereas FA usually takes a much longer timeframe to allow value to be realised and at some stage for the SP to reflect this much more profitable company.
The problem I have with that is in this day and age, can anyone look ahead 2-5 years with any degree of (relative) certainty?
Sure if its a FTSE 100 co. maybe, but even then.....
So, for me, I find it easier to work on short time frames and take potentially smaller wins (5-25%) over a few days/weeks then hold out for maybe 3 years to hope ultimate value will be realised on much bigger gains.